• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, September 9, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

A CNIO team discovers how telomere involvement in tumor generation is regulated

Bioengineer by Bioengineer
March 10, 2021
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The results show for the first time that telomeres respond to external signals that induce cell proliferation and that blocking these signals can interfere with cancer cells becoming immortal

IMAGE

Credit: PLOS Genetics

The Telomeres and Telomerase Group led by Maria A. Blasco at the Spanish National Cancer Research Centre (CNIO) continues to make progress in unravelling the role that telomeres -the ends of chromosomes that are responsible for cellular ageing as they shorten- play in cancer. The CNIO team was among the first to propose that shelterins, proteins that wrap around telomeres and act as a protective shield, might be therapeutic targets for cancer treatment. Subsequently, they found that eliminating one of these shelterins, TRF1, blocks the initiation and progression of lung cancer and glioblastoma in mouse models and prevents glioblastoma stem cells from forming secondary tumours. Now, in a study published in PLOS Genetics, they go one step further and describe for the first time how telomeres can be regulated by signals outside the cell that induce cell proliferation and have been implicated in cancer. The finding opens the door to new therapeutic possibilities targeting telomeres to help treat cancer.

The CNIO group was also the first to find a link between TRF1 and the PI3K/AKT signalling pathway. This metabolic pathway, which also encompasses mTOR, is one of the pathways most frequently affected in numerous tumorigenic processes. However, it was not known whether preventing TRF1 regulation by this pathway can have an impact on telomere length and its ability to form tumours. AKT acts as a transmitter of extracellular signals triggered by, among others, nutrients, growth factors and immune regulators, to the interior of cells. CNIO researchers Raúl Sánchez and Paula Martínez, directed by Maria A Blasco, set out to determine the involvement of telomeres in this signalling pathway.

To do this, the researchers modified the TRF1 protein in cells to make it unresponsive to AKT, using the gene-editing tool CRISPR/Cas9. This way, TRF1 and the telomeres became invisible to any extracellular signals transmitted by AKT. Telomeres in these cells shortened and accumulated more damage; most importantly, the cells were no longer able to form tumours, indicating that telomeres are important targets of AKT and its role in cancer development.

“Most importantly, we found that when TRF1 can’t be phosphorylated by AKT, the latter has a lower potential to generate tumours,” explains Blasco.

The paper shows that telomeres are among the most important intracellular targets of the AKT pathway to form tumours, since, although neither the function of AKT nor of any of the thousands of proteins that are regulated by it was altered, only blocking AKT’s ability to modify telomeres was sufficient to slow tumour growth.

The next step will be to generate genetically modified mice with telomeres that are invisible to AKT. The authors anticipate that these mice will be more resistant to cancer.

###

The study was funded by the Spanish Ministry of Science and Innovation, the Carlos III Health Institute, the Spanish State Research Agency, the European Research Council, the European Regional Development Fund, the Autonomous Community of Madrid, the Botín Foundation and Banco Santander through Santander Universities, and World Cancer Research.

Reference Article: AKT-dependent signaling of extracellular cues through telomeres impact on tumorigenesis. Raúl Sánchez-Vázquez, Paula Martínez, Maria A. Blasco (PLOS Genetics, 2021). DOI: doi.org/10.1371/journal.pgen.1009410

Media Contact
Department of Communications
[email protected]

Original Source

https://www.cnio.es/en/news/publications/cnio-team-discovers-how-telomere-involvement-in-tumour-generation-is-regulated/

Related Journal Article

http://dx.doi.org/10.1371/journal.pgen.1009410

Tags: AgingBiochemistryBiologycancerCell BiologyDisease in the Developing WorldGeneticsHealth Care Systems/ServicesHealth ProfessionalsMolecular Biology
Share12Tweet8Share2ShareShareShare2

Related Posts

Relative Fat Mass Predicts Type 2 Diabetes Risk

September 9, 2025

King’s College London Researcher Pioneers Advances in Psychiatric Genomics with Innovative Polygenic Scoring

September 9, 2025

Glaucoma Treatment Insights from French Nationwide Survey

September 9, 2025

Preduodenal Portal Vein: Diverse Cases and Surgery Insights

September 9, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    151 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Relative Fat Mass Predicts Type 2 Diabetes Risk

Revolutionary Atomic-Level Etching Technique Enhances Hafnium Oxide, Paving the Way for Next-Generation Semiconductors

King’s College London Researcher Pioneers Advances in Psychiatric Genomics with Innovative Polygenic Scoring

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.